Abivax Overview
Abivax Target Price
Analysts' 12-month price predictions for ABVX.
Get informed when a big investor buys or sells
+ FollowShare Price
$97.5
Average Target Price
$116.60
19.6% upside
19.6% upside5 analysts in the last 4 months
High: $136 | Low: $90
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-03 | Wolfe Research | $136 | 39.5% upside |  |
| 2026-06-02 | Wedbush | $90 |  7.7% downside | |
| 2026-06-02 | Truist Financial | $135 | 38.5% upside | |
| 2026-06-02 | Morgan StanleyJudah Frommer | $132 | 35.4% upside | |
| 2026-06-02 | JefferiesFaisal Khurshid | $90 | 7.7% downside | |
| 2026-02-24 | WedbushDavid Nierengarten | $110 | 12.8% upside | |
| 2026-01-09 | Morgan Stanley | $145 | 48.7% upside | |
| 2026-01-08 | BTIGJulian Harrison | $150 | 53.8% upside | |
| 2026-01-08 | Oppenheimer | $131 | 34.4% upside | |
| 2025-12-18 | GuggenheimYatin Suneja | $175 | 79.5% upside | |
| 2025-12-16 | Piper Sandler | $142 | 45.6% upside | |
| 2025-11-24 | Truist FinancialGregory Renza | $140 | 43.6% upside | |
| 2025-11-05 | Wolfe Research | $176 | 80.5% upside | |
| 2025-10-13 | BarclaysEtzer Darout | $142 | 45.6% upside | |
| 2025-10-10 | Guggenheim | $150 | 53.8% upside | |
| 2025-10-06 | BTIG | $120 | 23.1% upside | |
| 2025-09-25 | JMP Securities | $114 | 16.9% upside | |
| 2025-07-23 | Leerink PartnersThomas Smith | $74 | 24.1% downside | |
| 2025-07-18 | JMP SecuritiesJason Butler | $33 | 66.2% downside | |
| 2025-03-20 | Morgan Stanley | $12 | 87.7% downside | |
| 2024-09-10 | Piper SandlerAlexander Potter | $42 | 56.9% downside | |
| 2024-05-20 | BTIGJulian Harrison | $43 | 55.9% downside | |